News

Those who take tirzepatide, the drug sold as Zepbound and Mounjaro, could lose more weight than those who take semaglutide, ...
In a 72-week trial, people taking Zepbound lost 50 pounds on average, compared with about 33 pounds for people taking Wegovy.
Nearly 32% of Zepbound users lost at least a quarter of their body weight, compared with about 16% of Wegovy users. In both ...
The head-to-head examination of these weight loss drugs provides doctors with 'robust' data on their effectiveness.
A new study shows that people Zepbound lost about 50% more weight than those using Wegovy. It was the first head-to-head ...
In study after study, injected GLP-1 weight loss medications appear to work better on average for women than they do for men.
First results from NHS patients getting Wegovy through an app show treatment via smartphone works as well as in-person ...